Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
Clinical trial NCT03144271 · COMPLETED
Trial details
- NCT number
- NCT03144271
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-11
- Primary completion
- 2007-10-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.